Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Melphalan With Stem Cell Transplant for Primary Systemic Amyloidosis
NCT00003353Phase 2Completed
- Sponsor
- Eastern Cooperative Oncology Group
- Start
- Nov 1998
- Primary completion
- Dec 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan in primary systemic amyloidosis, sponsored by Eastern Cooperative Oncology Group. Started Nov 1998; status: completed.
02
Drugs
melphalan
03
Conditions
primary systemic amyloidosis
Beyond the preview
Go deeper on NCT00003353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00003353.